Enveric Biosciences Q1 EPS $(1.08) Up From $(14.64) YoY

Benzinga Newsdesk www.benzinga.com Negative 56.5%

Neg 56.5% Neu 0% Pos 0%

Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(1.08) per share. This is a 92.62 percent increase over losses of $(14.64) per share from the same period last year.